Literature DB >> 7827359

Disseminated intravascular coagulation and severe peripheral neuropathy complicating ketoacidosis in a newly diagnosed diabetic child.

R Bonfanti, E Bognetti, F Meschi, S Medaglini, A D'Angelo, G Chiumello.   

Abstract

Disseminated intravascular coagulation is a very rare complication of diabetic ketoacidosis. Central nervous system palsy but not peripheral neuropathy has been reported in these patients. On the other hand, signs of peripheral neuropathy may also be present at the onset of diabetes, but they are usually reversible within a few days after correction of the metabolic derangement. We describe an unusual case of mononeuritis multiplex syndrome still present after 2 months of follow-up in a child with diabetic ketoacidosis complicated by disseminated intravascular coagulation at the onset of insulin-dependent diabetes. These neurological impairments may be consistent with functional neural lesions due to vasa nervorum thrombosis and prolonged ischaemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827359     DOI: 10.1007/bf00570376

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  11 in total

1.  Clinical and laboratory features of type 1 diabetic children at the time of diagnosis.

Authors:  C Lévy-Marchal; L Papoz; C de Beaufort; J Doutreix; V Froment; J Voirin; P Czernichow
Journal:  Diabet Med       Date:  1992-04       Impact factor: 4.359

2.  Successful treatment of disseminated intravascular coagulopathy complicating diabetic coma.

Authors:  G Nicholson; G H Tomkin
Journal:  Br Med J       Date:  1974-11-23

3.  Diabetic keto-acidosis complicated by disseminated intravascular coagulation.

Authors:  M R Cooper; R A Turner; L Hutaff; R Prichard
Journal:  South Med J       Date:  1973-06       Impact factor: 0.954

4.  Ischemic mononeuropathy multiplex associated with diabetes mellitus.

Authors:  M C Raff; V Sangalang; A K Asbury
Journal:  Arch Neurol       Date:  1968-05

5.  Severe sensory motor polyneuropathy at the onset of diabetes mellitus. Total remission with testosterone therapy following recognition of associated hypogonadism.

Authors:  U M Kabadi
Journal:  Diabetes Care       Date:  1993-01       Impact factor: 19.112

6.  Disseminated intravascular coagulation in diabetic ketoacidosis.

Authors:  A H Barnett; J H Harrison
Journal:  Lancet       Date:  1979-07-14       Impact factor: 79.321

7.  Disseminated intravascular coagulation in diabetes mellitus, with reference to the role of increased platelet aggregation.

Authors:  H C Kwaan; J A Colwell; N Suwanwela
Journal:  Diabetes       Date:  1972-02       Impact factor: 9.461

8.  [Consumption coagulopathy and acidosis in the diabetic patient (author's transl)].

Authors:  A Larcan; H Lambert; M C Laprevote-Heully; P Alexandre
Journal:  Diabete Metab       Date:  1976-03

9.  Glycemic control and peripheral nerve conduction in children and young adults after 5-6 mo of IDDM. Wisconsin Diabetes Registry.

Authors:  C Allen; S C Duck; R L Sufit; H M Swick; D J D'Alessio
Journal:  Diabetes Care       Date:  1992-04       Impact factor: 19.112

10.  Neurologic complications of disseminated intravascular coagulation.

Authors:  R J Schwartzman; J B Hill
Journal:  Neurology       Date:  1982-08       Impact factor: 9.910

View more
  4 in total

Review 1.  Hyperglycemic comas in children: new insights into pathophysiology and management.

Authors:  Arlan L Rosenbloom
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

Review 2.  The spectrum of diabetic neuropathies.

Authors:  Jennifer A Tracy; P James B Dyck
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-02       Impact factor: 1.784

3.  Diabetic ketoacidosis-associated stroke in children and youth.

Authors:  Jennifer Ruth Foster; Gavin Morrison; Douglas D Fraser
Journal:  Stroke Res Treat       Date:  2011-02-22

4.  The management of diabetic ketoacidosis in children.

Authors:  Arlan L Rosenbloom
Journal:  Diabetes Ther       Date:  2011-01-12       Impact factor: 2.945

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.